Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Human Hypertension
|
December 1, 1995
Long-term moderate sodium restriction does not adversely affect the serum HDL/total cholesterol ratio
J M Geleijnse, J C Witteman, A A Bak, et al.
The American Journal of Clinical Nutrition
|
December 10, 2008
Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects
Kim van der Zander, Michiel L Bots, Annette A A Bak, et al.
Clinical Chemistry and Laboratory Medicine
|
January 13, 2001
Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population
W M Janssen, H Hillege, S J Pinto-Sietsma, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 1998
[Antithrombotic treatment following acute ischemic heart disease: acetylsalicylic acid and (or) oral anticoagulants?; ASPECT-II, a new study]
R F van Es, D E Grobbee, J W Deckers, et al.
Atherosclerosis
|
October 5, 2001
The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial
A E Hak, A A Bak, J Lindemans, et al.
Journal of Clinical Epidemiology
|
July 1, 1997
Efficiency optimization of the selection period in therapeutic trials
C K Moons, G A van Es, T Stijnen, et al.
The American Journal of Cardiology
|
September 12, 2000
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT])
G F Diercks, W M Janssen, A J van Boven, et al.
European Journal of Epidemiology
|
September 4, 2003
The Atherosclerosis Risk in Young Adults (ARYA) study: rationale and design
A Oren, L E Vos, C S P M Uiterwaal, et al.
Maturitas
|
October 9, 1999
Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness
M J de Kleijn, M L Bots, A A Bak, et al.
Maturitas
|
September 28, 2001
Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women
M E Ossewaarde, M L Bots, A A Bak, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Human Hypertension
|
December 1, 1995
Long-term moderate sodium restriction does not adversely affect the serum HDL/total cholesterol ratio
J M Geleijnse, J C Witteman, A A Bak, et al.
The American Journal of Clinical Nutrition
|
December 10, 2008
Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects
Kim van der Zander, Michiel L Bots, Annette A A Bak, et al.
Clinical Chemistry and Laboratory Medicine
|
January 13, 2001
Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population
W M Janssen, H Hillege, S J Pinto-Sietsma, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 1998
[Antithrombotic treatment following acute ischemic heart disease: acetylsalicylic acid and (or) oral anticoagulants?; ASPECT-II, a new study]
R F van Es, D E Grobbee, J W Deckers, et al.
Atherosclerosis
|
October 5, 2001
The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial
A E Hak, A A Bak, J Lindemans, et al.
Journal of Clinical Epidemiology
|
July 1, 1997
Efficiency optimization of the selection period in therapeutic trials
C K Moons, G A van Es, T Stijnen, et al.
The American Journal of Cardiology
|
September 12, 2000
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT])
G F Diercks, W M Janssen, A J van Boven, et al.
European Journal of Epidemiology
|
September 4, 2003
The Atherosclerosis Risk in Young Adults (ARYA) study: rationale and design
A Oren, L E Vos, C S P M Uiterwaal, et al.
Maturitas
|
October 9, 1999
Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness
M J de Kleijn, M L Bots, A A Bak, et al.
Maturitas
|
September 28, 2001
Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women
M E Ossewaarde, M L Bots, A A Bak, et al.
Page
of 3